Axsome Therapeutics, Inc.
US ˙ NasdaqGM ˙ US05464T1043

SecurityAXSM / Axsome Therapeutics, Inc.
InsiderJacobson Mark L.
This page shows the track record and history of Jacobson Mark L. insider trades in Axsome Therapeutics, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Jacobson Mark L. in AXSM / Axsome Therapeutics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

AXSM / Axsome Therapeutics, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Jacobson Mark L. in AXSM / Axsome Therapeutics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2024-05-29 7,910 74.3127 7,910 74.3127 587,813 13 71.0700 -25,649 -4.36

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

AXSM / Axsome Therapeutics, Inc. Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2025-09-17 2025-09-16 4 Jacobson Mark L. AXSM Common Stock S - Sale D 114.2300 -40,000 -4,569 0
2025-09-17 2025-09-16 4 Jacobson Mark L. AXSM Common Stock M - Exercise D 4.8500 15,000 73 40,000
2025-09-17 2025-09-16 4 Jacobson Mark L. AXSM Common Stock M - Exercise D 4.9500 25,000 124 25,000
2025-09-17 2025-09-16 4 Jacobson Mark L. AXSM Common Stock S - Sale D 116.1900 -5,783 -672 0
2025-06-10 2025-06-09 4 Jacobson Mark L. AXSM Common Stock S - Sale D 110.4400 -25,000 -2,761 5,783
2025-06-10 2025-06-09 4 Jacobson Mark L. AXSM Common Stock M - Exercise D 8.0200 25,000 200 30,783
2025-05-28 2025-05-28 4 Jacobson Mark L. AXSM Common Stock S - Sale D 103.4500 -20,000 -2,069 5,783
2025-05-28 2025-05-28 4 Jacobson Mark L. AXSM Common Stock M - Exercise D 6.4700 20,000 129 25,783
2025-05-28 2025-05-27 4 Jacobson Mark L. AXSM Common Stock S - Sale D 104.6600 -20,673 -2,164 5,783
2025-05-28 2025-05-27 4 Jacobson Mark L. AXSM Common Stock M - Exercise D 6.4700 20,673 134 26,456
2024-08-09 2024-08-09 4 Jacobson Mark L. AXSM Common Stock S - Sale D 84.2600 -47,739 -4,022 5,783
2024-08-09 2024-08-09 4 Jacobson Mark L. AXSM Common Stock M - Exercise D 4.0400 47,739 193 53,522
2024-05-29 2024-05-29 4 Jacobson Mark L. AXSM Common Stock S - Sale D 74.3127 -7,910 -588 5,783
2024-05-29 2024-05-29 4 Jacobson Mark L. AXSM Common Stock M - Exercise D 1.3000 13,693 18 13,693
2024-04-01 2024-04-01 4 Jacobson Mark L. AXSM Common Stock S - Sale D 77.2420 -24,662 -1,905 0
2024-04-01 2024-04-01 4 Jacobson Mark L. AXSM Common Stock M - Exercise D 1.3000 24,662 32 24,662
2022-03-08 2022-03-04 4 Jacobson Mark L. AXSM Restricted Stock Units A - Award D 47,990 47,990
2022-03-08 2022-03-04 4 Jacobson Mark L. AXSM Employee Stock Option (Right to Buy) A - Award D 29.91 89,405 89,405
2021-11-15 2021-11-12 4 Jacobson Mark L. AXSM Employee Stock Option (Right to Buy) A - Award D 39.26 41,638 41,638
2021-03-09 2021-03-05 4 Jacobson Mark L. AXSM Restricted Stock Units A - Award D 22,163 22,163
2021-03-09 2021-03-05 4 Jacobson Mark L. AXSM Employee Stock Option (Right to Buy) A - Award D 65.02 41,638 41,638
2020-03-19 2020-03-17 4 Jacobson Mark L. AXSM Restricted Stock Units A - Award D 18,645 18,645
2020-03-19 2020-03-17 4 Jacobson Mark L. AXSM Employee Stock Option (Right to Buy) A - Award D 45.14 60,880 60,880
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)